Difference between revisions of "TG002450"
Jump to navigation
Jump to search
(Created page with "{{TransitionGroup |mz1=1209.042 |nrt=82.251 |ntransition=8 |peptide=PE001080 |prt=41.051 |rt=41.030 |spectra=MS_31_UO1_MS2_new_measurement_02 |z1=4 }}") |
|||
| Line 1: | Line 1: | ||
{{TransitionGroup | {{TransitionGroup | ||
| − | |||
| − | |||
| − | |||
|peptide=PE001080 | |peptide=PE001080 | ||
| − | |||
| − | |||
|spectra=MS_31_UO1_MS2_new_measurement_02 | |spectra=MS_31_UO1_MS2_new_measurement_02 | ||
|z1=4 | |z1=4 | ||
}} | }} | ||
Latest revision as of 23:52, 12 May 2021
| Peptide | K.SLGNVN[H5N3]FTVSAEALESQELCGTEVPSVPEHGR.K (PE001080) |
|---|---|
| Sequence | SLGNVNFTVSAEALESQELCGTEVPSVPEHGR |
| Glycans(s) | H5N3 (N6) |
| Mod(s) | 57.021 (C20) |
| Molecular Weight | 4,850.133 |
| Charge | 4+ |
| Protein | A2M (P01023) |
| Spectrum File | MS_31_UO1_MS2_new_measurement_02 |
| Method | Orbitrap Fusion-Lumos, DDA (EThcD pd HCD), nano LC-MS/MS |
| Analytical Fraction | No enrichment |
| Sample | Human Serum |